Literature DB >> 15264022

The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.

V Pistone Creydt1, M Fernandez Miyakawa, F Martín, E Zotta, C Silberstein, C Ibarra.   

Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) colonizes the large intestine causing a spectrum of disorders, including watery diarrhea, bloody diarrhea (hemorrhagic colitis), and hemolytic-uremic syndrome. It is estimated that hemolytic-uremic syndrome is the most common cause of acute renal failure in infants in Argentina. Stx is a multimeric toxin composed of one A subunit and five B subunits. In this study we demonstrate that the Stx2 B subunit inhibits the water absorption (Jw) across the human and rat colonic mucosa without altering the electrical parameters measured as transepithelial potential difference and short circuit current. The time-course Jw inhibition by 400 ng/ml purified Stx2 B subunit was similar to that obtained using 12 ng/ml Stx2 holotoxin suggesting that both, A and B subunits of Stx2 contributed to inhibit the Jw. Moreover, non-hemorrhagic fluid accumulation was observed in rat colon loops after 16 h of treatment with 3 and 30 ng/ml Stx2 B subunit. These changes indicate that Stx2 B subunit induces fluid accumulation independently of A subunit activity by altering the usual balance of intestinal absorption and secretion toward net secretion. In conclusion, our results suggest that the Stx2 B subunit, which is non-toxic for Vero cells, may contribute to the watery diarrhea observed in STEC infection. Further studies will be necessary to determine whether the toxicity of Stx2 B subunit may have pathogenic consequences when it is used as a component in an acellular STEC vaccine or as a vector in cancer vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264022     DOI: 10.1590/s0100-879x2004000600004

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  11 in total

1.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

2.  Infectious diarrhea: Cellular and molecular mechanisms.

Authors:  Kim Hodges; Ravinder Gill
Journal:  Gut Microbes       Date:  2010-01

3.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

4.  Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.

Authors:  Claudia Silberstein; Virginia Pistone Creydt; Elizabeth Gerhardt; Pablo Núñez; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

5.  Inhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21.

Authors:  Elizabeth Gerhardt; Mariana Masso; Adrienne W Paton; James C Paton; Elsa Zotta; Cristina Ibarra
Journal:  Infect Immun       Date:  2013-06-03       Impact factor: 3.441

6.  Development of an experimental hemolytic uremic syndrome in rats.

Authors:  Elsa Zotta; Nestor Lago; Federico Ochoa; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

7.  Microalbuminuria and early renal response to lethal dose Shiga toxin type 2 in rats.

Authors:  Federico Ochoa; Gisela Oltra; Elizabeth Gerhardt; Ricardo Hermes; Lilian Cohen; Alicia E Damiano; Cristina Ibarra; Nestor R Lago; Elsa Zotta
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-01-19

8.  Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods.

Authors:  Romina J Fernández-Brando; Leticia V Bentancor; María Pilar Mejías; María Victoria Ramos; Andrea Exeni; Claudia Exeni; María del Carmen Laso; Ramón Exeni; Martín A Isturiz; Marina S Palermo
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo.

Authors:  Tao Li; Wei Tu; Yuenan Liu; Peng Zhou; Kun Cai; Zhan Li; Xiong Liu; Nianzhi Ning; Jie Huang; Shenghan Wang; Jian Huang; Hui Wang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

10.  Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.

Authors:  Luisina Martorelli; Sergio Garbaccio; Daniel A Vilte; Adriana A Albanese; María P Mejías; Marina S Palermo; Elsa C Mercado; Cristina E Ibarra; Angel A Cataldi
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.